BRIC-RGCB receives ₹7 crore grant to develop automated blood-based cervical cancer diagnostic device
GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims·
Public-private partnerships in biotechnology: a key GS3 Science & Technology and healthcare innovation case.
Why in news
The Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) received a ₹7 crore grant from the MAHA MedTech Mission to develop an automated blood-based cervical cancer diagnostic device.
Background
The project is supported by the Anusandhan National Research Foundation (ANRF), Indian Council of Medical Research (ICMR), and the Gates Foundation. The development involves collaboration between BRIC-RGCB, IndZita Biotech Private Limited, and Karkinos Healthcare Private Limited (KHPL).
Facts for Prelims
- FactGrant amount: ₹7 crore for automated blood-based cervical cancer diagnostic device
- BodyANRF: Anusandhan National Research Foundation
- BodyICMR: Indian Council of Medical Research
- BodyMAHA MedTech Mission: Supporting body for the grant
Prelims practice question
With reference to the development of the automated blood-based cervical cancer diagnostic device, consider the following statements:
- The project receives a grant of ₹7 crore from the MAHA MedTech Mission.
- The development is supported by the Indian Council of Medical Research (ICMR).
- The project is funded exclusively by the Gates Foundation without any government involvement.
Which of the statements given above is/are correct?
- (a)1 only
- (b)1 and 2 only
- (c)2 and 3 only
- (d)1, 2 and 3
Show answer
Answer: (b) 1 and 2 only — Statements 1 and 2 are correct. Statement 3 is incorrect: The project is also supported by ANRF and ICMR.
For Mains
Q. Discuss how public-private partnerships and multi-institutional funding models can accelerate the development of affordable diagnostic technologies for non-communicable diseases in India.
Dimensions to cover in your answer
- Diagnostic accessibility: Reducing reliance on invasive procedures through non-invasive blood-based screening
- Funding synergy: Leveraging multi-agency support (ANRF, ICMR, Gates Foundation) to bridge R&D funding gaps
- Commercialization pathway: Integrating private biotech firms to scale laboratory innovations into clinical tools
Keywords: Public-Private Partnership · Diagnostic Innovation · Biotechnology · Non-communicable Diseases · Medical Research
More Science & Technology notes
- Hindi AI responses average only 79.3 per cent accuracy due to retrieval failures · 19 October 2026
- 83% of 18,388 towers in Assam face high cyclonic wind risk · 18 October 2026
- FSSAI issues advisory: Perishable items must be transported under controlled-temperature conditions · 18 October 2026
- Ponnam Prabhakar announces G.O. Ms. No. 48 for Telangana Road Safety Fund guidelines · 18 October 2026
- Aster CMI Hospital performs India's first pediatric ABO-incompatible kidney transplants on two males · 18 October 2026
- VP Radhakrishnan commissions INS Samarthak, first indigenously built multi-purpose vessel at Karwar · 18 October 2026
Something wrong, or something missing?
Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.